ResearchCategory

A variety of tumor immunotherapies that activate T cells are effective in treating many types of cancer. However, due to the existence of the blood-brain barrier, immune cells cannot effectively infiltrate brain tumors, which is also an important reason why immunotherapy is difficult to effect on glioblastoma.   The blood-brain… Continue Reading Successfully cross the blood-brain barrier, will CAR-T become a new breakthrough in the treatment of brain cancer?

  Traditional gene therapy and emerging gene editing therapy for Duchenne Muscular Dystrophy (DMD), which one is better? Some recent research may give us some new thinking.   There are approximately 300,000 DMD patients worldwide. Due to the presence of mutations, patients are unable to produce dystrophin normally, causing atrophy… Continue Reading Traditional gene therapy vs. gene editing, who is the king of DMD treatment?

I The development of immunology has gone through a very long process, and people’s understanding of the immune system has been very shallow for a long time. Although people have long recognized the importance of IL-2 as a cytokine, its role is not known. Studies in the 1960s found that… Continue Reading Tumor immune cell therapy, difficult to move forward

  Tumor immunotherapy can treat cancer by activating the body’s own immune system. However, tumor immunotherapy is a large class of treatments, including many research directions, such as checkpoint inhibitors, tumor vaccines, oncolytic viruses, and adoptive cell transfer (ACT).   In general, adoptive cell therapy refers to T cell-related therapies,… Continue Reading Where is the new generation of cell therapy technology?

  Seeing life and death, people will become numb, probably people will always have such misunderstandings about doctors. But no one will be more excited than them when revolutionary therapies emerge.   Sixty-three children with B-cell acute lymphoblastic leukemia who have no other treatment options have a very low chance… Continue Reading The next step of CAR-T therapies

  Cough is a protective respiratory reflex and is also a symptom of respiratory diseases (cold, flu, pneumonia, tuberculosis, bronchitis, asthma, sinusitis). Use cough to discharge respiratory secretions or foreign bodies (sticky, bacteria, fibers) to keep the airway clean and unobstructed. Causes of cough are acute, chronic bronchitis and pneumonia,… Continue Reading 20% of cough is caused by medication

  I. How does the existing drug lower blood sugar? Most of the glucose digested and absorbed from food is transported to various tissues of the body along with blood circulation, generating heat for human use, and a small part is converted into glycogen, stored in liver and muscle tissue,… Continue Reading SGLT-2 inhibitor, a new class of hypoglycemic drugs

  Pneumonia is a common infectious disease in pediatric clinical practice and an important public health problem worldwide. According to the World Health Organization (WHO), pneumonia is the leading cause of death among children under five years of age. The incidence of pneumonia has obvious seasonality, and the incidence rate… Continue Reading Is pneumonia in children related to vitamin A deficiency?

  Once upon a time, bacterial infections claimed the lives of thousands of people. With the discovery and widespread clinical use of penicillin in the first half of the 20th century, antibiotics have greatly reduced the mortality caused by bacterial infections and made a great contribution to the health of… Continue Reading In the face of super bacteria, monoclonal antibody became the weapon of the post-antibiotic era